Use of clot-busting drug for stroke has almost doubled

08/26/2013 | HealthDay News

An analysis of information from almost 1,700 U.S. hospitals found an increase in the use of clot-busting tissue plasminogen activator as a therapy for ischemic stroke, according to a study in the journal Circulation: Cardiovascular Quality and Outcomes. Among patients who were transported to hospitals swiftly and who did not have conditions that could increase the drug's risks, usage grew from 43% in 2003 to 77% in 2011. "We should be providing intravenous tPA to all eligible patients, which means that nearly a quarter of them are still missing that opportunity," researcher Dr. Lee Schwamm said.

View Full Article in:

HealthDay News

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Chief Executive Officer
CarePoint Health Plan
Jersey City, NJ
Regional Director, Southeastern Region - State Affairs
America's Heatlh Insurance Plans (AHIP)
Washington, DC
Assistant General Counsel
Cardinal Health
Columbus, OH
Pharmacy Care Manager
National Association of Chain Drug Stores
Arlington, VA
Senior Director, Research
America's Health Insurance Plans (AHIP)
Washington, DC